reason report
decent volum usa gross profit growth integr
bottom line publish updat model account
result updat guidanc overal quarter
decent view though increas guidanc due entir tax
reform beat rel model discret
tax item restructur acquisit relat cost materi
sound rush large-scal near-
term on-go challeng retail usa oper
incom beat estim gross profit grew y/i basi
retail oper incom also exceed estim
wholesal divis result lag behind model seem
highli focus rx volum growth market share agre
volum import howev believ reduc rate
plan pbm order gain volum result gross margin
percentag revenu usa retail remain pressur
maintain mp pt stand
pressur retail usa deliv decent result revenu adj
oper incom exceed estim rx fill compar store
increas y/i in-lin model retail market share
increas bp total rx volum increas
y/i high view though much increas
like recent acquir nr store adjust
oper incom usa retail exceed estim
despit fact compar retail sale declin y/i
highlight retail front-stor gross margin improv
past year
merger vertic integr way transform
ineluct light on-going consolid
industri manag field sever question capit
alloc prioriti view pursu opportun ceo
stefano pessina explain alway open deal
explain believ chang possibl
merg health plan main transform adapt
store work futur custom requir rather
need merg chang manag believ adapt
organ invest data analyt
on-going store optim differenti program
net debt total capit
price-to-earnings lt ep growth
ep
compani inform leerink partner llc research
ep exclud acquisition-rel cost acquisition-rel amort non-recur item includ lifo adjust revenu billion
pleas refer page import disclosur price chart analyst certif
outlin core prioriti may signal intent move closer
gain even better purchas power ceo stefano pessina
outlin main point strategi start today earn
call drive growth consolid volum partnership
acquisit use volum buy best-in-class rate
better competitor view may alreadi success
meet goal estim wbad scale
volum manag refrain comment possibl
deal link believ closer relationship could
make sens difficult believ increment buy-sid
synergi could realiz also believ could
signific opportun drive save specialti link
pivot toward futur store pilot invest
data analyt manag seem commit adapt
evolv market drive volum store
part process includ on-going store updat move
differenti competitor earli result support
manag effort beauti differenti store quarter
deliv retail margin higher non-beauti store central
differenti process harvest data analyt drive
better perform effici manag highlight
spent new system next three year
spend least improv data-captur applic
insight drive cost save effici includ updat
compani pharmaci manag system plan
launch pilot store come month test area includ optic
hear care lab along on-going test valu loyalti
integr on-track acquir
store consist previou guidanc transfer
would complet spring end quarter
transfer transfer three distribut center
relat inventori expect begin still two
restructur program in-process first focus mainli
integr effort includ cost capital-expenditure spend
result annual synergi second
program optim store perform close store
incur pre-tax charg also result
annual save end also highlight
invest annual higher wage employe
impact
guidanc increas attribut tax reform adj ep guidanc
rais prior rang
increas midpoint increas guidanc due
entir tax reform prior guidanc cash tax benefit
benefit adj ep rais
increas ep estim reflect
tax reform ep increas well
largest global pharmaci led retail pharmaceut wholesal
organ world walgreen us drugstor chain largest pharmaci chain
us store count industri size improv purchas power brand-nam
recognit improv store traffic overal volum health plan self-insur
employ seek reduc medic cost via restrict network believ walgreen in-stor
clinic may provid attract altern plan walgreen nation presenc
also attract mani plan view provid larg corpor broad access
view gener launch wave next sever year posit impact
bottom line walgreen balanc reward custom loyalti program help lower
print ad cost bring individu market benefit recent work increas wba
privat brand product share mix well new front-end merchandis strategi
posit impact same-stor sale profit addit walgreen recent deal
allianc boot offer promis long-term synergi global
growth back lost share esrx network disput
although grow accept narrow network remain risk walgreen provid
health plan wide array servic includ infus specialti dispens lab servic
hospit partnership primari care servic case walgreen also earli
mover advantag purchas jv boot deal walgreen
pbm may advantag case make retail chain payer agnost
mani strength believ retail channel face signific challeng
includ increasingli competit environ seek creat
restrict prefer narrow network deal effort captur store traffic volum
medacorp specialist check indic retail rate reduc
case keep pressur retail gross margin
furthermor on-going gener launch believ wave
larg behind us becom increasingli difficult show gross margin expans
retail also believ transact posit busi stock howev
deterior lose share even though deal approv investor
sentiment stock name appear low lastli threat amazon enter
pharmaci servic space continu weigh stock believ
retail exposur sinc own pbm given risk
concern rate share market perform
next month expect share trade ep
would put stock price multipl reflect transact increment
volum recent narrow restrict network deal synergi believ
posit win share becom extens network vast array clinic
capabl believ new manag team take step reduc overal cost
increas sale higher margin front-stor product posit retail rate
remain signific pressur brand gener price also headwind
becom aggress overal respons market also overhang
unlik abat time soon given challeng concern rate share
competit high retail pharmaci industri highli competit contract
pbm manufactur also competit walgreen compet chain
independ drug store well mail order prescript provid groceri store on-line
pharmaci pharmaceut vendor chang competit landscap
impact rx volum neg impact compani sale earn
macroeconom regulatori climat uncertainti continu econom slowdown
 would bode poorli sinc above-averag unemploy rate drive lower
level consum spend would decreas prescript drug util regulatori
environ also fair amount uncertainti time impact variou
healthcar reform provis could materi impact wba oper nation emphasi
reduc healthcar cost could also spawn reimburs pressur new way contain
healthcar cost devis implement
intern exposur execut risk walgreen merger allianc boot increas
exposur intern market increas currenc exposur regulatori risk
wba partnership uniqu approach contract distribut
compani fail execut vision accret could expect
season time cost adjust swing result front-end sale
prescript sale compon season sale also lumpi depend
holiday line calendar sever cold cough flu season
magnitud compani lifo provis also fluctuat given quarter depend
inventori level sale inflat also swing result contribut earn
miss beat
potenti amazon entri amazon may seek disrupt pharmaci market
enter retail market buy build contract pbm news topic
pose headlin risk share amazon would formid competitor mail cash
sale
revenu
revenu
gross profit sg spread bp
equiti earn ab
share allianc boot associ
sale acquisit adjust
revenu
revenu
net earn attr nci
revenu
total non-gaap adjust tax
incom statement model fiscal year end august mm
compani report leerink partner llc estim
revenu
revenu
equiti earn allianc boot
sale acquisit adjust
compani report leerink partner llc estim
revenu
revenu
revenu
revenu
adjust equiti earn
elimin unalloc
sale
incom statement model fiscal year end august mm
compani report leerink partner llc estim
incom statement model fiscal year end august mm
sale
equiti earn allianc boot
share allianc boot associ
previous held equiti interest
tax earn equiti method invest
net incom attrib non-control interest
net incom attrib walgreen
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
loss sale busi
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
compani report leerink partner llc estim
